NeuroPace reiterates $98M-$100M 2026 revenue target while advancing AI and IGE pipeline
Source: SeekingAlpha
2026-03-03 21:02:43 ET
More on NeuroPace
- NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
- NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- NeuroPace GAAP EPS of -$0.08 beats by $0.08, revenue of $26.6M beats by $1.81M
- NeuroPace sees Q4 revenue of about $26.6M
Read the full article on Seeking Alpha
For further details see:
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
-0.49% G/L:
$14.16 Last:
25,913 Volume:
$14.17 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
